Best Semaglutide Providers

RxSpan MD prints a monthly figure on every product it sells, names its four dispensing pharmacies and two prescribing physicians, and publishes no refund policy anywhere on its site.

Willow prints a monthly figure for every dose of its compounded semaglutide and tirzepatide, sells each as a weekly shot or a tablet that dissolves under the tongue, adds an NAD+ injection, and names the five pharmacies that fill its orders.

SkinnyRx sells compounded semaglutide and tirzepatide, prints a four-plan ladder for tirzepatide with the exact charge stated at checkout, and publishes only an introductory first-month figure for semaglutide.

Wellorithm prints a monthly figure on each brand-name GLP-1 page and lists its compounded semaglutide and tirzepatide on a separate checkout storefront, while the GLP-1 landing page it leads with shows no price at all.

MEDGm sells brand-name GLP-1s beside an unnamed compounded lane, and the figure on every brand tile is a membership fee that explicitly excludes the medication.

Embody sells compounded semaglutide and tirzepatide from a store that prices every supply length, and runs separate offer pages for sermorelin, NAD+ and glutathione at one flat monthly figure each, though its offer page, its store and its terms print three different prices for the same GLP-1.

Found sells compounded semaglutide and tirzepatide at one all-in price at every dose and publishes the whole grid by plan term and payment track, though each "month" it prices is a 28-day billing cycle.

HumeCare+ pairs compounded semaglutide and tirzepatide with body-composition tracking, publishes a licensed provider directory and a state-by-state coverage page, and keeps its prices on landing pages its homepage does not link to.

Collective prices compounded semaglutide and tirzepatide flat at every dose, and charges a required membership once a year on top of the drug.

DudeMeds sells compounded and brand-name semaglutide and tirzepatide plus two NAD+ preparations, and most of its plans are a prepaid block of months shown as a per-month figure, with the full charge printed underneath.

Bodybuilding Health+ prices seven compounds compared here on plan ladders, and two of those ladders cost more per month the longer you commit — including the tirzepatide lane the seller itself badges "Best Value".

Gala GLP-1 prices NAD+ and sermorelin by the twenty-eight-day supply and says so, and charges at checkout before a clinician has seen the intake — refunding in full if nothing can be prescribed.

Idgie Health prices NAD+, glutathione, sermorelin, GHK-Cu and both GLP-1s by plan length, prints the full charge for every multi-month plan, and names its prescribing physician and its pharmacy.

Nouri names its compounding pharmacy, its trading name, its street address and its telephone number, prints three plan cadences with the total for each, and says compounded therapies are not FDA-approved in the same breath.

Renlo Health prices compounded semaglutide, tirzepatide, NAD+ and glutathione at one figure per drug regardless of dose and names its pharmacy, but its own pages attach two different meanings to the GLP-1 headline price.

CareBareRX names four pharmacies, its physicians with NPI numbers and the company behind the brand, then prints its NAD+ and GLP-1 prices everywhere except its own product pages.

Lavender Sky Health publishes a price for every peptide it sells against the specific pharmacy that would fill it — nine pharmacies named, quantity by quantity — and states plainly that none of those figures includes the consultation fee it prices separately.

He & She MD is one of the few sellers on this roster that names its dispensing pharmacies outright, and one whose plans page and product pages publish different prices for the same shorter plans.

Raeliva publishes nine per-compound monthly prices, says its providers are licensed in every state, and warns its own readers that the effective rate on a prepaid plan is not a monthly payment.

Renn names four separate pharmacies, each with a telephone number and a web address, and says it serves all fifty states. Its published figures are floors rather than rates at a stated dose.

PepHaus prints three plan lengths with a per-month figure and the prepaid total beside each, says on the product page itself that it is not a research-only website, and claims a certificate of analysis in every box — a certificate that is not reachable anywhere on the site.

Rx.com runs its own program for compounded semaglutide and tirzepatide at one price across every dose, and its other peptide pages point to companies that set their own prices.

The Aesthetic Concierge prices its weight-loss medication in five-week blocks rather than months, includes basic blood work in its kick-off fee, and prints a states heading with nothing under it.

RxPepsDirect charges one $39 fee per order for the medical visit and then steps out of the transaction: Optimal Balance Pharmacy bills the patient directly at its own wholesale price, and that price is printed for every peptide on the site.

OrderlyMeds carries a June 2026 federal warning letter, names five dispensing pharmacies — one of which carries two federal letters of its own — and gives a different pharmacy roster on two of its pages.

Ozari Health is the only seller in this batch that publishes a fifty-row table naming which of its two pharmacies fills in each state — and it dates its own prices.

Aquivia Health prints a per-month headline for both weight-loss drugs and then bills every four weeks — thirteen shipments a year — and its own two figures for the same drug do not reconcile with each other.

Big Easy Weightloss names eleven pharmacies and publishes each one's shipping exclusions, then claims to serve all fifty states on the same site where it says its physicians are still applying for the rest.

Fella Health names two pharmacies and includes lab work in its NAD+ program fee, and publishes no price for either weight-loss molecule on any page a reader reaches before its quiz.

PeRx, the trading name of Wellness MD Group PC, lists twenty-six compounds and blurs the price on every one of them, publishing a floor and a range on a separate pricing page instead.

Science & Co prices compounded semaglutide and tirzepatide by plan term, at one price for every dose and with no membership fee, while its sermorelin and glutathione pages are marked coming soon.

Clover Meds carries a June 2026 federal warning letter, names its pharmacy with a street address, lists the four states it operates in, and every rung of its plan ladder reconciles.

CoraDoc prices its peptides in four and ten-week blocks rather than months, and runs a countdown sale whose banner figures contradict the program cards on the same page.

Rylo Health LLC names its dispensing pharmacy and its clinical group by name, prices six compounds at a flat rate that does not move with dose, and sells each on a quarterly plan or month to month, with the quarterly rate the lower of the two.

Coivas prints its own price-verification month on the page, publishes a comparison table whose first column is its own, and gives itself three different legal names across three pages.

Heally, Inc. runs a marketplace that puts a free consultation in front of three priced peptide programs, and bills only when a patient reorders rather than on a standing subscription.

Body Good Studio carries a 2025 federal warning letter, prices five tracked compounds openly, and publishes a line on its own home page conceding that its brand names and final copy are still pending clinical and legal review.

CLYR Health prices seven tracked compounds by weekly dose with the whole ladder visible before any intake, names its pharmacy, and puts a competitor's cream price in the same table as its own.

Thrivelab names 503A compounding as its source and condemns the research-peptide gray market by name — then publishes no price for any peptide it lists, only for its two weight-loss molecules.

Good Life Meds names its pharmacies and prints four green "Passed" test badges on every product page, with no document behind any of them.

MD Total Wellness prices its peptides and NAD+ by the vial with the vial size printed, on a price list of its own that its main service pages do not link to.

SuperHealthy Rx publishes seven per-compound prices and renders two of them without a currency symbol at all — the GLP-1 cards read as bare numbers.

PeptideMD prices peptides by tier rather than by molecule, and its homepage and its pricing page quote two different figures for the same single-peptide tier.

RX Bella prints a monthly starting figure on every card of a twenty-protocol peptide menu and on its two GLP-1 injections. Nine of those protocols are stacks priced as one, and no card names a dose.

TeleDocs360 charges one flat monthly price at every standard dose and prints the two exceptions to that rule in the same paragraph, which is a rarer kind of honesty than a flat-price claim on its own.

REX MD sells sermorelin inside a testosterone program whose subscription is published as a range covering whichever medication is prescribed, so no sermorelin figure is recorded. Its recorded prices are brand-name semaglutide: the Wegovy pill with provider care at one monthly figure across every dose, and the Wegovy pen, bought through NovoCare, the manufacturer's pharmacy platform.

Chronos Body, Health & Wellness is a Louisiana clinic that prices weight-loss medication by the injection in its office and by the two-to-three-month package by post, and it says openly it is not a national platform.

HealthiCare, run by Sunshine Health Studios Inc., prices sermorelin and NAD+ in two routes each, and names its dispensing pharmacy and the states it cannot ship sterile preparations to — in an article, not on the treatment page.

ZYP Medical prices peptides as four-week stacks rather than by the month, lists the seven states it serves by name, and states in its own words that its compounded GLP-1 medicines are not FDA-approved.

Potere Health MD prices its weight-loss medication by the milligram rather than the month, publishes a certificate-of-analysis page with no certificate on it, and prints two different figures for the same maintenance tier.

Rixa Health prices its weight-loss ladders in four- and five-week blocks rather than months, prints the weekly milligram at every rung, and says the figure is a pass-through of what the compounding pharmacy charges.

Options Medical Weight Loss prices NAD+ and glutathione on their own product pages by the month, says its weight-loss injections are made in 503B outsourcing facilities, and prints an FDA compounding disclaimer under each figure.

SynergyRx prices four tracked peptides at exactly the same figure and its two GLP-1s separately, prints that figure before the product name rather than after it, and runs terms of service naming a different company as the operator.

Bridgeside Telehealth prices every peptide identically, at $99 for the consultation and $300 for the medication if it is prescribed, and charges nothing for the visit when therapy is judged inappropriate.

Cabana names its pharmacy, publishes that pharmacy's ten-state licensing gap — and sells three injectable products after telling readers the same pharmacy does not dispense sterile compounds.

Desert Mobile Medical is a Scottsdale practice whose peptide line is a single compound: BPC-157 at $399 a month with every telemedicine visit folded in, sold beside its in-home primary care and IV services.

Eviora MD prints a monthly starting figure on every card of an open twenty-card peptide menu, sells eight tracked peptides on their own, and publishes no price for its GLP-1 programs.

Form by GBY prices GHK-Cu by the unit and NAD+ and glutathione by the month on single-compound pages, and sells its weight-loss medicines only inside a three-component formula.

Heros Health names four pharmacies while telling readers it uses one, publishes three different entry prices for the same weight-loss program, and ships an NAD+ page whose unfilled template sections render as text.

JRNYS prints each longevity product's price only on the other product's page — read either one alone and the NAD+ and glutathione figures come out reversed.

Lifeforce sells peptides only to members, bills them every 25 days rather than monthly, and puts a paid membership and a one-off diagnostic in front of the first order — three separate figures that are never added together on the page.

New Wave Health prints a monthly starting figure beside every product on a twenty-item peptide menu, and sells compounded semaglutide and tirzepatide with no price on either.

Next Vial names its pharmacy with a street address and lists the forty-nine states it serves, and then hides every price but one behind a plan selector.

PepScribe prices six tracked compounds individually from one catalog and says in its own FAQ which pharmacy class fills them — 503A — while declining to name the pharmacy itself, because the one that fills your order depends on your state.

PreventiveMD prints an all-in monthly figure for each compounded protocol and, on the same page, breaks its branded lane into a membership fee plus a medication rate as two named lines — and it publishes a list of the peptides it will not sell yet, with the review dates it is waiting on.

Factor Health MD publishes the deepest plan ladder in this batch — four terms plus a pay-as-you-go rung priced by milligrams — and names two different states as its governing law in one contract.

Jently names the compounding pharmacy that fills its prescriptions, with its street address and its 503A status, and prices five tracked compounds at the same monthly floor.

NoBsRx prices compounded semaglutide and tirzepatide at two dose tiers on one open page and names four pharmacies, but its own terms disagree about whether the price includes the medication.

LVNG RX puts a monthly starting figure on each single-peptide program and on both weight-loss injections. The weight-loss figures sit on its home page; the program pages that advertise flat, transparent pricing print none.

Nolu prices three weight-loss options at the same figure regardless of dose, and every one of those figures is quoted on a twelve-month plan. It says it serves all fifty states and, two lines later, that some services may not be available in all of them.

The NP 2 Go publishes a full dose ladder for its two weight-loss drugs under two different programs, prices sermorelin and NAD+ by the vial, and prints three different state counts on its own site.

Lovely Meds carries a 2025 federal warning letter, names seven dispensing pharmacies outright, and prints weight-loss body copy on a sermorelin product page.

Green Cap Health sells compounded semaglutide and tirzepatide at one monthly price at any dose, and prices NAD+ and sermorelin injections as add-ons to those plans. It publishes two different monthly figures for the same GHK-Cu foam on two of its own pages.

ElitePhysiqMD publishes the widest prescription peptide catalog on this roster — fifteen of the sixteen compounds this site tracks, each with a figure in visible text — and every one of those figures is a member rate that sits on top of a separate monthly membership charge.

Coby Health LLC sells sermorelin and NAD+ on stacked subscription lanes, and its sermorelin page carries two different price tables that disagree about what the monthly lane costs.

Fifty 410 Health carries a February 2026 federal warning letter and publishes its prices only in its sitemap — the pricing pages are not linked from the site a reader lands on.

Loop Health sells peptides inside a membership, prices four tracked compounds at a flat monthly rate that does not climb with dose, and states a state count rather than publishing a list.

Luma Meds says it is available in all fifty states on its product page and only in certain states in its terms, and its compounded tirzepatide plan card renders no price at all.

Meto puts a $149 blood panel in front of the prescription and bills in two published lines: a $29 monthly membership charged $320 a year, and the medication itself at a monthly rate that starts at $85 for BPC-157.

AquaVita NextGen prices its two peptide products as ten-injection kits covering a ten-week program, not as monthly subscriptions — and files them, along with a lipotropic vitamin injection, under a heading it wrote itself: Peptides.

InjectCo publishes two different monthly prices for the same compounded semaglutide program on two of its own pages, and prints "We Only Use FDA-Approved, Trusted Products" above copy describing compounded drugs.

Premium Health carries a February 2026 federal warning letter, names three pharmacies, prices both weight-loss molecules by the month — and ships them every ninety days.

Elevated Health carries a 2025 federal warning letter, publishes a four-rung ladder for both weight-loss molecules, and runs terms of service that govern a different website entirely.

Biopreventative carries a 2025 federal warning letter and publishes three incompatible answers to the question of which states it serves — including a state list that names Alaska after its product pages exclude it.

Layla publishes three different tirzepatide prices on one page, two mutually exclusive discount labels on another, and a savings total that does not match its own arithmetic.

NuuVim names two pharmacies with their addresses, prices the oral and injectable form of each molecule identically, and builds its whole price presentation on a three-month billing block.

Fidelity Medical Clinic advertises "$99 a Month" for a figure its own pricing box says buys two months, and charges one tirzepatide price for eight doses, seven doses and four doses.

Voxy Health prints four plan lengths for each weight-loss drug with the billing cadence written beside every rate, so a prepaid figure can never be mistaken for a monthly one. It sells three tracked peptides with no price attached to any of them.

FancyMeds carries a 2025 federal warning letter, names two pharmacies — one of which carries a letter of its own — and puts the other drug's price card directly under each product's own.

Vigormeds publishes two different monthly figures for its NAD+ injection and two more for its NAD+ nasal spray, with identical descriptions and nothing distinguishing them, and one product card whose price is printed with no number in it.

Ambiante Health and Wellness is the fourth seller found serving a byte-identical peptide menu under a different company and a different price list, and it prices seven tracked compounds on its own.

BluefitMD prices sermorelin and NAD+ with a full package ladder, publishes two different per-month figures for the same six-month sermorelin package, and links a weight-loss page from every page that returns not-found.

Ivologist publishes no price on any product page. The only figure it attaches to itself is a range inside its own blog comparison table, which is where this record’s single price comes from and why it is recorded as a range.

Lyfe Rx carries a 2025 federal warning letter naming its own website, and today publishes a flat storefront price for bremelanotide and for two glutathione products with no billing period stated anywhere on the listing.

Magnolia Regenerative Medicine publishes a flat per-compound rate for twelve of the peptides this site tracks, on one catalog page, with the billing cadence printed beside each figure.

Nava Health publishes a full price list with a member and a non-member column for every line, prices NAD+ and glutathione by the infusion at three strengths each, and adds a third column for two membership tiers on its packages.

Take10Rx prices sermorelin, glutathione and two forms of NAD+ per month on a quarterly plan, and its own product page asks whether a buyer can pay monthly instead — which is the clearest sign that the per-month figure is not a monthly charge.

Villas Health carries a 2025 federal warning letter naming its own website, and prints a one-time price and a subscription price side by side on every product, several of them marked down from a struck-through figure.

CaroCare Wellness publishes a month-by-month price ladder for both weight-loss drugs, naming the dose at each step, and offers a three-month bundle priced below the sum of its parts.

Alan Health prints a per-month figure on each of three product pages and a footnote under each one that names a different prepayment term — six months, two months and three months — so the three numbers are not the same kind of number.

TMates prices semaglutide, tirzepatide, NAD+ and sermorelin by the month in an open catalog, states plainly that it is not a compounding facility, and lists two branded drugs at a figure a fraction of their list price.

MedSol Rx publishes a plan ladder whose arithmetic reconciles at every rung, and separately tells readers on its own product pages that the same medicine typically costs two to eight times what it charges.

GoodGirlRx carries a February 2026 federal warning letter and prints a compounded-tirzepatide price on three product pages that do not sell tirzepatide — each one quoting that page's own figure.

Alyve prices seven tracked-compound products across injectable and sublingual forms, and runs a site-wide banner quoting a tirzepatide figure that matches neither of its own tirzepatide products.

JulyMD carries a 2025 federal warning letter, serves every state but one, and runs terms of service that hand your data to a pharmacy network belonging to a different brand.

Andrew Meds lists forty-four states by name and publishes a four-rung ladder for three compounds, then says on the same page that it serves all fifty and the District of Columbia.

California Trim Clinic advertises a monthly starting figure for each weight-loss drug and footnotes it with a three-month requirement, and lists thirteen tracked peptides on a therapy page that carries no price at all.

Ready Med carries a June 2026 federal warning letter, prints one price in its hero and a different one three times in the body of the same page, and answers its own question about which states it serves with text about something else.

Tablet Health lists NAD+ as a treatment on two of its own pages and prints no figure on either, while every GLP-1 it sells carries a monthly rate.

Mojoon publishes its catalog in Chinese for the US market, prices five tracked-compound products by a course of treatment it never defines in days, and leaves two of the five open-ended with a plus sign.

VAULT Men's Health is one of the few sellers on this roster to publish a price for BPC-157, TB-500, CJC-1295, ipamorelin and GHK-Cu individually — and it attaches no dose or vial size to any of them.

RyzeRx prices every product on its own page, from single peptides to vial-by-vial weight-loss strengths, and says on none of them what period or supply the figure buys.

Citizen Meds sells every product as a one-month supply and renews every twenty-three days, and its NAD+ page prints two different struck-through prices for the same product on the same page.

Tru2u runs a shopping cart on prescription drug products while its own terms state, in capitals, that it does not sell or dispense any drug product — and none of its prices carries a dose, a strength or a period.

Celia Rx runs an open storefront where every peptide carries a flat item price and the onboarding consultation is a line item of its own — and where one nasal spray is dearer than a bottle six times its concentration.

Momentum Health 360 carries a June 2026 federal warning letter that names its own website and its FDA establishment identifier, and its NAD+ page renders a price for the two-month plan while the one-month lane prints no figure at all.

Evolve Telemed publishes a thirty-three item treatment catalog carrying GHK-Cu and glutathione, no price on any of it, and an article that names the gray-market peptide labels and tells readers to avoid them.

Genesis Lifestyle Medicine gives sermorelin and NAD+ their own pages inside a clinic menu that also sells branded weight-loss pens, and puts a price on none of it.

Joey Med publishes a detailed article on what semaglutide costs — every figure in it about the market rather than about itself. Its own plan pages print a four-week price without naming the drug inside, and its NAD+ page prices a three-month supply.

Royal Medical Centers publishes its whole peptide catalog as eleven product pages, prices each one for a month and for two months, and prints an FDA compounding disclaimer on every page.

TRT Nation prices sermorelin, NAD+, glutathione and tirzepatide by the month and footnotes a minimum purchase of two and a half or three months beneath most of them, so the monthly figure is not the smallest commitment.

YOURx Health prices six tracked peptides by the month on one protocol page, and sells every one of its weight-loss medicines combined with vitamin B12, so none of those four carries a price scoped to the drug.

BetterMe Rx runs its NAD+ and sermorelin pages in English and Spanish, answers the cost question with a comparison rather than a number, and publishes no figure a reader can act on.

Brightmeds publishes a price for every product it sells — to search engines. The figures live in the page’s structured data and appear nowhere a reader can see them, so this record credits no published price.

MANÜ Telehealth sells a product it calls Compounded Semaglutide and prints a benefits tile headed FDA-Approved on the same page — a claim its own product name contradicts.